A61K35/48 - CPC Classification Index

ClassID:

20637 ⎘

A61K35/48 - CPC Classification

Classification description:

Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells Reproductive organs

Sub-classes:

A61K35/50 » Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells 954
A61K35/51 » Umbilical cord; Umbilical cord blood; Umbilical stem cells 594
A61K35/52 » Sperm; Prostate; Seminal fluid; Leydig cells of testes 84
A61K35/54 » Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells 202

Recent Application in this class:

20260097085

2026-04-09

AMNIOTIC FLUID COMPOSITION AND METHOD OF USING

20250073278

2025-03-06

METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS

20240200034

2024-06-20

Uterine-derived regenerative cell compositions and uses thereof

20230227784

2023-07-20

UTERINE-DERIVED REGENERATIVE CELL COMPOSITIONS AND USES THEREOF

20220347248

2022-11-03

Composition for Elongating Telomeres

20220233606

2022-07-28

AN AMNIOTIC FLUID COMPOSITION AND METHOD OF USING

20220118026

2022-04-21

MAPC TREATMENT OF BRAIN INJURIES AND DISEASES

20220110982

2022-04-14

MAPC TREATMENT OF BRAIN INJURIES AND DISEASES

20210299185

2021-09-30

MAPC TREATMENT OF BRAIN INJURIES AND DISEASES

#10

20210299184

2021-09-30

Human uterine cervical stem cell population and uses thereof

#11

20210128794

2021-05-06

Method comprising contacting tissue with a cross-linkable polyester prepolymer

#12

20210077538

2021-03-18

Methods and compositions for treatment of penile defects

#13

20200405774

2020-12-31

METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS

#14

20200205400

2020-07-02

Sperm storage media comprising MHY 1485 for enhancing sperm quality and function

#15

20200032215

2020-01-30

Methods and compositions for production of fallopian tube epithelium

#16

20190369088

2019-12-05

Compositions Comprising Human Embryonic Stem Cells and Their Derivatives, Methods of Use, and Methods of Preparation

#17

20190240261

2019-08-08

Composition containing endometrial decidual cells for treating damage to the endometrium or enhancing implantation functions

#18

20190194608

2019-06-27

ISOLATION OF NON-EMBRYONIC STEM CELLS AND USES THEREOF

#19

20190091377

2019-03-28

Method comprising contacting tissue with a cross-linkable polyester prepolymer

#20

20190060372

2019-02-28

Amniotic fluid composition and method of using

#21

20180325959

2018-11-15

METHODS OF TREATING ERECTILE DYSFUNCTION

#22

20180298077

2018-10-18

Glucagon-like-peptide-2 (GLP-2) analogues

#23

20180296609

2018-10-18

MAPC treatment of brain injuries and diseases

#24

20180193387

2018-07-12

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#25

20180179492

2018-06-28

ISOLATION OF NON-EMBRYONIC STEM CELLS AND USES THEREOF

#26

20180117093

2018-05-03

MAPC treatment of brain injuries and diseases

#27

20180028575

2018-02-01

METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS

#28

20170326182

2017-11-16

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#29

20170313966

2017-11-02

Processing and use of reproductive tract fluids to improve the in vitro production of mammalian embryos

#30

20170258727

2017-09-14

Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof

#31

20170247660

2017-08-31

PROGENITOR CELLS, METHOD FOR PREPARATION THEREOF AND USES THEREOF

#32

20170224740

2017-08-10

Methods for treating traumatic brain injury with amnion-derived cellular cytokine solution (ACCS) or amnion-derived multipotent progenitor (AMP) cells

#33

20170114327

2017-04-27

Proliferative primary human Sertoli cell cultures and their applications

#34

20170014456

2017-01-19

METHODS AND SYSTEMS FOR ENDOMETRIAL TREATMENT

#35

20160355563

2016-12-08

Glucagon-like-peptide-2 (GLP-2) analogues

#36

20160354413

2016-12-08

ENCAPSULATED CELLS FOR TREATING LOW TESTOSTERONE IN MALE SUBJECTS

#37

20160310543

2016-10-27

Cell composition for treatment of uterine tissue and method for producing same

#38

20160237400

2016-08-18

ISOLATION OF NON-EMBRYONIC STEM CELLS AND USES THEREOF

#39

20160151424

2016-06-02

Amniotic membrane preparations and purified compositions and anti-inflammation methods

#40

20160129051

2016-05-12

Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment

#41

20160129050

2016-05-12

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#42

20160129049

2016-05-12

Purified amniotic membrane compositions and methods of use

#43

20160060594

2016-03-03

ISOLATION OF NON-EMBRYONIC STEM CELLS AND USES THEREOF

#44

20160053021

2016-02-25

Regulating transplant rejection of donor and embryonic stem cell-derived tissues and organs

#45

20160000835

2016-01-07

HUMAN UTERINE CERVICAL STEM CELL POPULATION AND USES THEREOF

#46

20150238539

2015-08-27

COMPOSITION FOR BRAIN-NEURON PROTECTION AND BRAIN-DISEASE PREVENTION, ALLEVIATION OR TREATMENT COMPRISING MUSKRAT MUSK

#47

20150174173

2015-06-25

STEM CELL TREATMENT FOR RADIATION EXPOSURE

#48

20150125431

2015-05-07

Glucagon-like-peptide-2 (GLP-2) analogues

#49

20150104470

2015-04-16

IMMUNE MODULATION BY PERI-LYMPHATIC OR INTRA-LYMPHATIC CELL THERAPY

#50

20140356410

2014-12-04

BIODEGRADABLE AND BIOCOMPATIBLE NANO COMPOSITE T-PLATE IMPLANT AND A METHOD OF SYNTHESIZING THE SAME

#51

20140234270

2014-08-21

TREATMENT WTH ALPHAT SELECTIVE LIGANDS

#52

20140212393

2014-07-31

Compositions and methods for the treatment of lysosomal storage disorders

#53

20140186312

2014-07-03

Method comprising contacting tissue with a cross-linkable polyester prepolymer

#54

20140147511

2014-05-29

Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof

#55

20140120070

2014-05-01

Process of preparing human multipotent stem cells co-expressing CD34 and CD73

#56

20140057350

2014-02-27

Method of isolating human embryonic stem cells in minimal essential medium

#57

20140057250

2014-02-27

Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation

#58

20140051164

2014-02-20

Method for storing a preparation of human embryonic stem cells

#59

20140051110

2014-02-20

Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation

#60

20140050706

2014-02-20

Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation

#61

20130295056

2013-11-07

Generation of Histocompatible Tissues Using Nuclear Transplantation

#62

20130280344

2013-10-24

Amniotic membrane preparations and purified compositions and anti-inflammation methods

#63

20130195994

2013-08-01

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#64

20130195993

2013-08-01

Purified amniotic membrane compositions and methods of use

#65

20130195992

2013-08-01

Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment

#66

20130189235

2013-07-25

Methods of treating spinal cord injury and minimizing scarring

#67

20130183387

2013-07-18

Methods for treating pustular psoriasis

#68

20130122486

2013-05-16

Method of partially differentiating hES cells

#69

20130023726

2013-01-24

Blastocyst culture supernatant as a fertility agent in blastocyst transfer

#70

20120328690

2012-12-27

Amniotic membrane preparations and purified compositions and anti-inflammation methods

#71

20120276625

2012-11-01

Mesenchymal stem cells produced from human pluripotent stem cells

#72

20120269880

2012-10-25

Purified amniotic membrane compositions and methods of use

#73

20120269761

2012-10-25

Method comprising contacting tissue with a cross-linkable polyester prepolymer

#74

20120230941

2012-09-13

Methods for treating nervous system injury and disease

#75

20120207849

2012-08-16

Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment

#76

20120207848

2012-08-16

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#77

20120093784

2012-04-19

Peptide amphiphile suspension to prevent or reduce tumor formation from administered embryonic stem cells

#78

20120014921

2012-01-19

Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells

#79

20110274663

2011-11-10

Pharmaceutical composition containing human mesenchymal stem cell

#80

20110268709

2011-11-03

Generation of Histocompatible Tissues Using Nuclear Transplantation

#81

20110262407

2011-10-27

TREATMENT WITH ALPHA7 SELECTIVE LIGANDS

#82

20110250280

2011-10-13

Microencapsulation process of sertoli cells, microcapsules obtained and use for treatment of type I diabetes mellitus

#83

20110250185

2011-10-13

TUMOR SUPPRESSION USING PLACENTAL STEM CELLS

#84

20110243901

2011-10-06

Cell therapy for the treatment of lysosomal storage disorders

#85

20110189301

2011-08-04

METHOD FOR PREPARING CONTACT LENS-SHAPED AMNIOTIC DRESSING

#86

20110129520

2011-06-02

Anti-Adhesion Barrier Wound Dressing Comprising Processed Amniotic Tissue and Method of Use

#87

20110044954

2011-02-24

Methods of producing germ-like cells and related therapies

#88

20110027333

2011-02-03

Retinal pigment epithelial cells differentiated from embryonic stem cells with nicotinamide and activin A

#89

20100310570

2010-12-09

MAPC TREATMENT OF BRAIN INJURIES AND DISEASES

#90

20100266552

2010-10-21

TREATMENT OF CHRONIC LUNG DISEASE

#91

20100247495

2010-09-30

Treatment of Muscular Dystrophy

#92

20100215714

2010-08-26

Treatment of stroke and other acute neural degenerative disorders using postpartum-derived cells

#93

20100040588

2010-02-18

Procurement, Isolation, and Cryopreservation of Endometrial/Menstrual Cells

#94

20100015243

2010-01-21

METHOD FOR PREPARING MATERIALS HAVING ANTITHROMBOTIC ACTIVITY FROM MUSKRAT MUSK AND MATERIALS OBTAINED FROM THE METHOD

#95

20100008890

2010-01-14

MAPC therapeutics without adjunctive immunosuppressive treatment

#96

20100003339

2010-01-07

FERTILITY AGENT

#97

20090264312

2009-10-22

METHOD FOR REMOVING DESIRED CHROMOSOME AND TAILOR-MADE MEDICAL TREATMENT UTILIZING THE SAME

#98

20090202496

2009-08-13

METHOD FOR REGENERATING AN IMMUNE SYSTEM

#99

20090191167

2009-07-30

ADULT SERTOLI CELLS AND USES THEREOF

#100

20090136457

2009-05-28

Methods of treating spinal cord injury and minimizing scarring

#101

20090123433

2009-05-14

Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation

#102

20090047256

2009-02-19

Biodegradable elastomers

#103

20090028833

2009-01-29

Proliferative Primary Human Sertoli Cell Cultures And Their Applications

#104

20090028832

2009-01-29

Compositions and methods for targeted tumor therapy

#105

20090004161

2009-01-01

Methods for treating pustular conditions of the skin

#106

20080318840

2008-12-25

Compositions of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer

#107

20080299087

2008-12-04

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#108

20080286267

2008-11-20

Methods for treating nervous system injury and disease

#109

20080241113

2008-10-02

Procurement, isolation and cryopreservation of endometrial/menstrual cells

#110

20080213332

2008-09-04

Cells Isolated from Placenta, Device for Isolating Same, and Uses Thereof

#111

20080171019

2008-07-17

Isolation and preservation of fetal hematopoietic and mesencymal system cells from non-controversial materials and/or tissues resulting from miscarriages and methods of therapeutic use

#112